Brufen 400 mg Tablets

Brufen is one of the most recognized brand names for Ibuprofen, a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and reduce inflammation. The brand was originally developed and patented by the Boots Group in the United Kingdom during the 1960s. Over the decades, the rights to the brand moved through several pharmaceutical giants, including Abbott Laboratories and Mylan.

Today, Brufen is owned by Viatris, a global healthcare company formed in 2020 through the merger of Mylan and Upjohn (a former division of Pfizer). While the brand has global reach, for the Italian market, the product is often manufactured locally at significant facilities such as the one in Merano (BZ) or through other European production sites. Viatris is headquartered in the United States and continues to manage Brufen as a core part of its pain management portfolio.